One emerging concept in depression is that disturbances in allosteric receptor–receptor interactions in highly vulnerable 5-HT1A heteroreceptor complexes can contribute to causing depression and become novel targets for the treatment of depression and anxiety [19,32,33]. The gene discussed is HTR1A; the disease is major depressive disorder.